Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

BACKGROUND: D2C7-IT is a novel immunotoxin (IT) targeting wild-type epidermal growth factor receptor (EGFRwt) and mutant EGFR variant III (EGFRvIII) proteins in glioblastoma. In addition to inherent tumoricidal activity, immunotoxins induce secondary immune responses through the activation of T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandramohan, Vidyalakshmi, Bao, Xuhui, Yu, Xin, Parker, Scott, McDowall, Charlotte, Yu, Yen-Rei, Healy, Patrick, Desjardins, Annick, Gunn, Michael D., Gromeier, Matthias, Nair, Smita K., Pastan, Ira H., Bigner, Darell D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542114/
https://www.ncbi.nlm.nih.gov/pubmed/31142380
http://dx.doi.org/10.1186/s40425-019-0614-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542114/
https://www.ncbi.nlm.nih.gov/pubmed/31142380
http://dx.doi.org/10.1186/s40425-019-0614-0

Ejemplares similares